Traumatic brain injury (TBI) elicits identifiable changes within the adult subventricular zone (SVZ). Previously, we demonstrated that EphB3/ephrinB3 interaction inhibits neural stem/progenitor cell (NSPC) proliferation and downregulating this pathway following TBI plays a pivotal role in the expansion of the SVZ neurogenic compartment. It remains unclear, however, what early initiating factors may precede these changes. Using hypoxyprobe-1 (HPb) to identify regions of low oxygen tension or hypoxia (<1%), we found HPb uptake throughout the cortex (CTX), corpus callosum (CC) and SVZ within the first 24 h following controlled cortical impact (CCI) injury. At this early time point, HPb co-localized with EphB3 in the SVZ. NSPC specific markers also colocalized with HPb staining throughout the lateral wall of the ventricle. To determine the cell autonomous effects of hypoxia on EphB3/ephrinB3 signaling in NSPCs, we used an in vitro model of hypoxia to mimic 1% oxygen in the presence and absence of soluble aggregated ephrinB3 (eB3). As expected, hypoxia stimulated the uptake of 5-bromo-2 0 -deoxyuridine (BrdU) and reduced cell death. Coincident with these proliferative changes, both Hif1-a and phospho (p)-AKT were increased while EphB3 expression was decreased. Stimulation of EphB3 attenuated hypoxia-induced proliferation and prevented phosphorylation of AKT. Hif1-a accumulation, on the other hand, was not affected by EphB3/ephrinB3 signaling. These findings indicate that this pathway limits the NSPC response to hypoxic stimuli. These studies also suggest that early transient changes in oxygen tension following localized cortical injury may initiate a growth-promoting response in the SVZ.
Introduction
Traumatic brain injury (TBI) is a progressive, potentially debilitating neurological condition initiated by mechanical forces, followed by a well-described cascade of secondary events including hypoxia, ischemia, excitotoxicity and free radical damage. In contrast, there is a stimulatory or growth-promoting effect on the neural stem/progenitor cell (NSPC) compartment in the subventricular zone (SVZ). The SVZ is the largest neurogenic region in the adult mammalian brain, lines the lateral ventricles (LV), and extends into the rostral migratory stream (RMS), where migrating neuroblasts navigate rostral through a ribbon of astrocytes to the olfactory bulb. [1] [2] [3] [4] [5] [6] Shortly after TBI, the proliferative rate of NSPCs within the ipsilateral SVZ is greatly enhanced, and over the first few weeks, migrating neuroblasts are observed exiting the RMS. [7] [8] [9] [10] [11] Interestingly, enhanced proliferation in the contralateral SVZ is also observed but to a lesser extent. 8, 9, 12 Whether these expansion and migratory changes are instituted to help counterbalance TBI-induced neuronal loss in an effort to maintain or restore function through trophic support or cellular replacement is under intense investigation.
Several factors have been implicated in regulating proliferation and migration 2, [13] [14] [15] [16] [17] in the SVZ, and among those are ephrins and erythropoietin-producing hepatocellular (Eph) family of receptor tyrosine kinases. Ephrins are membranebound ligands and tethered to the cell surface, by either a glycosylphosphatidylinositol (GPI)-anchor (A-class) or transmembrane domain (B-class). Eph receptors, which belong to the largest family of receptor tyrosine kinases, are also subdivided into two A-and B-class, based on their preferential binding for one particular ephrin subgroup. Therefore, receptor activation by ligand binding is a direct result of cell-cell contact, and interactions between ephrins and Eph receptors can result in bidirectional signaling from both the ligand and receptor. 18 Although the binding between ligands and receptors is considered very promiscuous, specific ligand-receptor interactions exist within each subclass. 19 Using a gene-targeted approach, we previously demonstrated that EphB3 forward signaling acts as a suppressive cue to limit NSPC proliferation and survival in the SVZ. Stimulation of this pathway using soluble recombinant ephrinB3-Fc chimeric molecules into the LVs attenuated TBI-induced proliferation in the neurogenic compartment. 7 Additional factors such as basic fibroblast growth factor (bFGF), brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF), transforming growth factor (TGF), sonic hedgehog (shh), and bone morphogenic proteins (BMPs) have also been shown to stimulate neurogenesis after brain injury. 20 Upregulation of multiple growth-promoting signaling pathways could be converging on the neurogenic compartment to stimulate neurogenesis. However, it is unclear whether these soluble molecules actually originate from the SVZ or are blood-borne factors that circulate through the SVZ vascular network after injury. 21 Additionally, activated astrocytes and microglial are both known to secrete a variety of growth factors that could create a gradient of trophic support that may affect neural progenitor cell activities. 22, 23 Although the orchestration of trophic signals leading to TBI-induced changes in the SVZ remains obscure, alterations in oxygen (O 2 ) tension or hypoxia could be an early stimulating event. Hypoxic cell culture conditions (<5% O 2 ) have demonstrated a strong correlation between low O 2 availability and the beneficial effects on stem cell functions such as enhanced proliferation, survival and differentiation. Although it has been shown that a majority of the dividing stem cell occupants of the SVZ are perivascular, others may possibly occupy hypoxic sub-compartments and be regulated by O 2 gradients. More intriguing is whether lowered O 2 tension created by brain trauma extends into the neurogenic compartments in the adult brain. As a starting point for testing these ideas, we screened for areas of low O 2 partial pressure ($1.3% O 2 or <10 mmHg) using Hypoxyprobe-1 (HPb) immunostaining in both shaminjured and TBI-injured mice. Our previous findings demonstrate that EphB3/ephrinB3 interactions negatively regulate NSPCs in the SVZ. Here, we further examined the cell autonomous effects of hypoxia on EphB3 signaling in cultured NSPCs.
Results
Pronounced hypoxia in the SVZ after TBI Cerebral hypoxia develops as part of the secondary injury following primary mechanical trauma to the brain. To visualize the presence of low oxygen in the injured tissue following a controlled cortical impact (CCI) model of TBI, animals were injected with 100 mg/kg of HPb (pimonidazole hydrochloride) or PBS (vehicle control) at the time of impact (0 h), 1.5 h and 24 h after CCI injury. HPb binds only to cells that have oxygen concentrations less than pO 2 of 10 mmHg (<1%), where protein adducts of reductively activated HPb are formed and then analyzed using rabbit anti-HPb and DAB staining on perfuse-fixed sagittal tissue sections. As expected, we observed the presence of HPb at the site of injury in the cortex (CTX) and underlying corpus callosum (CC) of CCI-injured mice (Figure 1c to f; brown staining). No staining was seen in HPb-injected shaminjured ( Figure 1a ) or PBS-injected CCI-injured mice (Figure 1b ). The greatest intensity of staining was seen at 1.5 h after impact. It was also the only time in which the hippocampus and dentate gyrus appear to be transiently HPb-positive ( Figure 1d ). Importantly, the area lining the LV, both dorsal and ventral subregions of the SVZ, was positive for HPb staining at all-time points but most notable at 24 h (Figure 1f ; black arrows) suggesting that the NSPCs residing in the lateral wall of the ventricle may be influenced by the low oxygen environment.
To determine which cells in the SVZ may be HPb-positive, we used double immunofluorescence and confocal image analysis on sagittal sections. At low magnification, we observed HPb expression (red) throughout the CTX, lateral wall of the ventricle and in the RMS (Figure 2b and d) at 1.5 h post-injury compared to sham-injured mice (Figure 2a ). In addition to the expected HPb expression on injured NISSL-positive neurons in the CTX (Figure 2e and f), we observed sustained HPb expression in the dorsal wall of the ventricle (Figure 2i and j) which extended ventral (data not shown) at 24 h post-TBI compared to sham-injured control (Figure 2g and h). HPb co-labeled with neuroblasts marker doublecortin (DCX; Figure 2k ) and NSPC markers MASH1 ( Figure 2l ) and glial fibrillary acidic protein (GFAP; Figure 2m ). These data indicate that HPb expression is present on multiple NSPC types in the SVZ following TBI.
EphB3 expression in the hypoxic SVZ after TBI
Our previous findings indicate that EphB3 receptor is expressed on NSPCs in the SVZ and limits their proliferation while in the presence of ephrinB3 ligand. 24, 25 In order to evaluate the effects of hypoxia on EphB3/ephrinB3 signaling, we first analyzed their regional expression in the SVZ and surrounding areas after TBI. Initially, we took advantage of a transgenic knock-in mouse where b-galactosidase (ephrinB3 bgal ) replaces the cytoplasmic domain to visualize ephrinB3 expression. We observed X-gal staining throughout the brain, including the striatum (St), septum, and CC ( Figure 3c ); however, we did not observe ephrinB3 within the SVZ (Figure 3c1 ). Co-labeling GFAP-positive NSPCs (green) and PSA-NCAM-expressing neuroblasts (red) on ephrinB3 bgal tissue sections show NSPCs residing in the SVZ exist along a border of ephrinB3 expression in the adjacent tissue (Figure 3a1 to c1). Neural progenitor cells in the SVZ, therefore, come in contact with and are regulated by neighboring ephrinB3. EphB3, on the other hand, is expressed in the SVZ, as previously described, 24 and shown here to co-label with HPb at 24 h after TBI (Figure 3d to g).
Next, we examined the cell autonomous effects of hypoxia on EphB3 signaling by culturing NSPCs at 1% oxygen in the presence or absence of ephrinB3. Using a monolayer of NSPCs derived from the SVZ, we confirmed the expression of EphB3 and other known ephrin-B ligands and Eph receptors whose expression are also implicated in regulating activities in the adult SVZ. 24, [26] [27] [28] Using RT-PCR, we confirmed that EphB3 is expressed on NSPCs, while ephrinB3 is absent. As expected, we also observed the presence of ephrinB1 and ephrinB2 ( Figure 4d ) and their cognate receptors EphB1 and EphB2 as well as EphA4, which has been shown to bind ephrinB3 with high affinity.
In addition to the presence of EphB3 and EphA4 transcripts, we show their cellular localization on NSPCs by immunofluorescence ( Figure 4a 
EphB3 stimulation limits hypoxia-induced proliferation in cultured NSPCs
We recently showed that interaction with ephrinB3 limits NSPC proliferation in the SVZ. 24, 25 This effect is blocked in the absence of EphB3 receptor, 24 demonstrating the specificity of the EphB3/ephrinB3 pathway. To overcome this inhibitory signal, EphB3 expression is downregulated, concomitant with increased NSPC proliferation following TBI. 24 In order to assess whether hypoxia could be an early initiating factor that modulates EphB3 signaling, we established an in vitro hypoxia assay by culturing SVZderived NSPCs in an airtight oxygen controlled humidified chamber that maintains 1% oxygen (hypoxia) or under standard culture conditions (normoxia). Using Western Blot analysis, we first observed that EphB3 expression on NSPCs was significantly reduced when exposed to hypoxia (HP) at 24 h (0.23 AE 0.04 compared to 0.38 AE 0.05 normoxia), 48 h (0.28 AE 0.04 compared to 0.41 AE 0.03 normoxia), and 72 h (0.27 AE 0.04 compared to 0.51 AE 0.08 normoxia), (Figure 5a and b). Conversely, phosphorylated AKT (p-AKT) levels, which are normally suppressed by EphB3 signaling, 24 are increased under hypoxia at 24 h (0.51 AE 0.09 compared to 0.25 AE 0.05 normoxia) and 72 h (1.03 AE 0.22 compared to 0.65 AE 0.11 normoxia) (Figure 5a and c).
We next assessed whether reduced EphB3 expression was concomitant with increased proliferation and whether the presence of soluble aggregated ephrinB3 (eB3), 29 which mimics the in vivo environment within the neurogenic compartment, would limit this effect. To test this, we treated SVZ-derived NSPCs with either 10 mg/mL eB3 or vehicle control and placed them under hypoxia or normoxia for 24, 48 and 72 h followed by 1 h incubation in 10 mM bromodeoxyuridine (BrdU) ( Figure 6 ). We observed a significant increase in the number of BrdU-positive NSPCs when exposed to hypoxia at 24 h (21.34 AE 0.8% compared to 16.9 AE 0.9% normoxia), 48 h (29.5 AE 0.8% compared to 24.4 AE 1.8% normoxia) and 72 h (28.7 AE 0.6% compared to 23.5 AE 0.6% normoxia) ( Figure 6e ). The total number of NSPCs per well was also significantly increased under hypoxia at 48 h (1312 AE 83.7 compared to 723.4 AE 86.9 normoxia) and 72 h (3248 AE 124.7 compared to 2158 AE 87.69 normoxia (Figure 6f ). However, the addition of eB3 significantly attenuated hypoxia-mediated proliferation at 24 h (21.34 AE 0.8% vehicle compared to 16.3 AE 1.7% eB3) and 48 h (29.5 AE 0.8% vehicle compared 26.6 AE 0.6% eB3) ( Figure 6d and e) which subsequently lead to an overall reduction in the total number of cells per well at 72 h (3248 AE 124.7 vehicle compared to 2577 AE 132.5 eB3) compared to vehicle control ( Figure 6f ). Finally, while the presence of eB3 attenuated hypoxia-induced proliferation, the numbers were not restored completely back to normoxic levels. Additionally, eB3 failed to attenuate hypoxia-induced proliferation in NSPCs derived from EphB3 À/À mice (data not shown).
These results indicate that eB3 limits the NSPC response to hypoxic stimuli via EphB3 forward signaling and suggests that the response in vivo could be enhanced on those NSPCs not directly in contact with eB3 ligand.
We also assessed whether eB3 could reduce proliferation by elevating cell death. Although we previously demonstrated reduced cell death in the presence of eB3, 24 we show that eB3 also reduced cell death under hypoxic conditions ( Figure 6g ) at 24 h (16.7 AE 1.2% vehicle compared to 5.6 AE 1.4%), 48 h (11.3 AE 1.6% vehicle compared to 3.5 AE 1.0%), and 72 h (7.8 AE 1.3% vehicle compared to 2.1 AE 0.9%).
Hif1-a is not regulated by ephrinB3/EphB3 signaling under hypoxia
Hypoxia inducible factor-1 alpha (Hif1-a) elicits the expression of a plethora of growth-promoting genes responsible for stimulating proliferation, survival and differentiation of stem cells under low oxygen conditions. [30] [31] [32] [33] To further elucidate the mechanism(s) by which ephrinB3/EphB3 signaling limits hypoxia-induced proliferation of NSPCs, we assessed whether EphB3 stimulation could prevent early activation of Hif1-a. Soluble eB3 was added at the time NSPCs were placed in hypoxia and the effects of EphB3 stimulation on early Hif1-a activation was assessed using Western Blot analysis. We found that Hif1-a expression increased at 12 h hypoxia exposure (0.44 AE 0.05 compared to 0.13 AE 0.03 normoxia) and was unaffected by the addition of either 10 mg/mL soluble aggregated eB3 (0.48 AE 0.07) or 10 mg/mL eB1 (0.33 AE 0.08) compared to vehicle control (0.4370 AE 0.05) (Figure 7a and b) . On the other hand, Hif1a accumulation was prevented following treatment with 50 mm AKT inhibitor LY294002 (0.14 AE 0.01 compared to vehicle 0.44 AE 0.05), as expected (Figure 7a and c) . The AKT/PI3 kinase pathway is a known inducer of Hif1-a under hypoxic conditions 34, 35 and is blocked following EphB3 activation. 36 Although we found the p-AKT levels to be significantly attenuated in the presence of eB3 (0.42 AE 0.06 compared to vehicle control 0.76 AE 0.09) under hypoxia vs. normoxia (0.18 AE 0.03) (Figure 7a and c) , it had no effect on the expression of Hif1-a ( Figure 7b ) suggesting a threshold of p-AKT inactivation must be reached to affect Hif1-a induction. These data also indicate that EphB3 limits hypoxia-induced proliferation in the presence of ephrinB3 through Hif1-a independent pathway(s).
Discussion
Adult NSPCs are localized to the SVZ/RMS and the dentate gyrus of the hippocampus. 37, 38 The cells residing in these adult neurogenic compartments are transiently stimulated to proliferate and migrate to areas of injury. 8, 12, 24 However, it remains unclear what early initiating factors precede these changes following the initial trauma. Here, using the HPb biochemical marker of hypoxia, we show HPb localization in the SVZ on GFAP-positive stem cells, MASH1-positive intermediate progenitor cells and DCXpositive neuroblasts in the first 24 h after TBI. This indicates that the local milieu within the SVZ niche has a pO 2 less than 10 mmHg ( 1%). Importantly, it is reasonable to believe that the NSPCs may respond favorably to this new hypoxic environment. Previously, we identified EphB3 as a negative regulator of NSPC activity which is downregulated in the SVZ after TBI. 24 Our current findings demonstrate the regional change in oxygen tension appears to correlate with reduced levels of EphB3 in the SVZ after TBI. NSPCs express HPb at 24 h post-TBI in the lateral wall of the ventricle, an area previously shown to have increased proliferation and enhanced survival. In order to examine the cell autonomous effects of hypoxia on NSPCs, we exposed them to a 1% oxygen environment in vitro. Similar to our previous in vivo findings, 24 we observed that the level of EphB3 expression on SVZ-derived NSPCs is significantly reduced in hypoxia compared to normoxia. This change is accompanied by increased Hif1-a expression, BrdU incorporation and reduced cell death. Importantly, p-AKT, known to be suppressed by EphB3 signaling, is significantly upregulated during this time. Therefore, downregulating this pathway on NSPCs in the SVZ following TBI may be preceded by localized transient hypoxia to initiate population expansion in the neurogenic compartment.
Neurogenesis in the SVZ is tightly regulated by ephrins and Eph receptors. Specifically, the proliferation of NSPCs expressing EphB3 receptor, are negatively regulated by the interaction with membrane-bound ephrinB3 ligand (eB3) in the tissue surrounding the SVZ. Although Eph receptors have been shown to be fairly promiscuous, ephrinB3 fails to suppress NSPC growth in the absence of EphB3. These previous findings solidify the role of EphB3/ephrinB3 interaction as a negative regulator in the SVZ. We therefore sought to understand how hypoxic NSPCs would respond in the presence and absence of eB3. We show that even though proliferation was increased in hypoxia, cells stimulated with eB3 grew significantly less than vehicle control. This suggests that hypoxia downregulates EphB3 expression to induce proliferation and that NSPCs in the SVZ may have a greater growth response to lowered oxygen when not directly in contact with eB3. While the early activation of hypoxia-inducible factor-1 alpha (Hif1-a) is unaltered by eB3 stimulation, growth suppression may be regulated downstream of Hif1-a by other signaling pathways known to be suppressed by Eph signaling such as PI3/AKT and ERK/MAPK. 19 Lowered oxygen conditions have been shown to mimic the embryonic setting, promote proliferation, survival and in some cases directed differentiation of neural crest stem cells and embryonic neural precursor cells. [30] [31] [32] Several studies indicate that redox metabolism in stem cells is differentially and uniquely regulated to protect them from oxidative damage. 39 The ability of stem cells to properly control redox balance is an important property of adult progenitor cells and could help explain why transient hypoxia may create a favorable environment in the neural stem niche following brain injury. 33, [40] [41] [42] Physiological hypoxia, on the other hand, exists not only during embryonic development but also in the adult mammalian brain where oxygen levels of interstitial tissue can range from one to 5%. 31 Although the importance of tissue hypoxia has been studied in the context of brain development, the effects of hypoxia on the adult neural stem cell niche is just now being investigated. There is sufficient evidence from a variety of experimental systems that describe the role of hypoxia in the proliferation, survival and differentiation of nonneural stem cell populations including embryonic stem (ES) cells, hematopoietic stem cells (HSCs) and trophoblast stem cells. 39, [43] [44] [45] [46] We found that NSPCs in the SVZ may also be regulated by changing oxygen conditions, especially in the injured environment. Although our studies addressed the co-labeling of HPb with Type A, B and C progenitor cells, it is also possible that others such as Olig2 and NG2-expressing cells may express HPb in the SVZ. Importantly, the direct role of Hif1-a in mediating cellular changes following hypoxia exposure on specific subpopulations of cells in the SVZ will be further investigated using additional models of brain injury.
Hif1-a is a crucial mediator of cellular adaptation to hypoxic stress and is the key element responsible for the regulation, under low oxygen tension, of many genes involved in important biological processes such as glycolysis, proliferation or angiogenesis. 6 This apparently universal response to hypoxia is consistent with the idea that oxygen levels may be an important component of the stem cell ''niche'' and that HIF activity can regulate the defining features of stem cells, including self-renewal and multipotency. Elucidation of the relevant molecular mechanisms governing proliferation, survival and differentiation of NSPCs exposed to hypoxia may further our understanding of the neural stem cell niche in the adult brain. We show that hypoxia induced Hif1-a expression in cultured NSPCs and that this effect is blocked in the presence of the AKT inhibitor LY294002. Although stimulation of EphB3 limited hypoxia-mediated p-AKT expression, early activation of Hif1-a was unchanged in the presence of eB3 suggesting that a threshold of p-AKT suppression may be necessary for blocking Hif1-a induction. Although it is possible that EphB3/ephrinB3 signaling may affect Hif1-a expression at later time points, this is unlikely as we would expect differences in HIf1-a to precede the proliferative changes observed at 24 h.
Recent findings indicate a low oxygen environment exists in the SVZ, as measured by intense HPb staining, under naïve conditions. 47 Conversely, our data indicates minimal HPb staining in the sham-injured SVZ which is greatly enhanced 24 h post-TBI. This difference may be due to the time at which the tissue was harvested following HPb injection. The previous study reported extracting the tissue 30 min after HPb injection; however, the half-life for HPb is 90 min. If residual systemic HPb still remains, false positive staining could occur in areas experiencing hypoxia during tissue extraction. This is not an indication of true hypoxia, as demonstrated in our studies where the time between HPb injection and tissue retrieval was 4 h. Using this biochemical marker, we were able to demonstrate that NSPCs in the SVZ experience early changes in oxygen tension as a result of cortical trauma. Given the beneficial role of transient hypoxia on stem cell activities, we believe this finding represents a novel mechanism regulating early events in the neurogenic compartment following TBI. We also show that EphB3/ephrinB3 negatively regulates the proliferation of NSPCs under homeostatic and hypoxic conditions and that downregulating this pathway is critical for NSPC expansion. Although our initial studies do not implicate EphB3 forward signaling in regulating Hif1-a, future studies will focus on confirming these results in vivo as well as identifying potential downstream pathways that may be interrupted within the hypoxic milieu as a result of EphB3 activation.
Materials and methods

Animals and CCI injury
The maintenance of CD1 and ephrinB3 bgal mice and genotyping using PCR analysis has been previously described. 25, [48] [49] [50] [51] Procedures related to animal use and care was approved by Virginia Tech and the University of Miami Animal Use and Care Committee. Male mice ages 2-4 months were anesthetized with ketamine and xylazine by i.p. injection and positioned in a stereotaxic frame. Body temperature was monitored with a rectal probe and maintained at 37 C with a controlled heating pad set. A 5 mm craniotomy was made using a portable drill over the right parietal-temporal CTX (À2.5 mm A/P and 2.0 mm lateral from bregma). Injury was induced by moderate CCI using the eCCI-6.3 device (Custom Design & Fabrication) at a velocity of 6 m/s, depth of 0.5 mm, and 150 ms impact duration. Sham controls received craniotomy only. Mice were injected once with 100 mg/kg HPb dissolved in 1 Â PBS (phosphate buffered saline; Hypoxyprobe Inc., Burlington, MA) at the time of injury (0 h), or at 1.5 h and 24 h postinjury. Mice receiving HPb at 0 h and 1.5 h were sacrificed 24 h later, and mice that received HPb at 24 h were sacrifice 4 h after injection (i.e. 28 h after injury). Under anesthesia, mice were sacrificed by transcardial perfusion, with 4% paraformaldehyde (PFA) in PBS. Brains were removed and post-fixed with 4% PFA for 4 h and transferred to 20% sucrose overnight, then embedded in OCT on dry ice.
Histology
For immunostaining, perfused-fixed tissue sections were blocked in 5% BSA for 1 h and incubated in primary antibodies overnight at 4 C (rabbit anti-HPb: 1/100; Hypoxyprobe Inc.; goat anti-DCX: 1/100, Santa Cruz; rabbit anti-GFAP: 1/1000, Dako; mouse anti-PSA-NCAM:1/1000, Chemicon; anti-BrdU: 1/100, Roche; anti-MASH1 1/100, BD Bioscience) as previously described. 24, 25 Sections were washed 3 times with 1X PBS and incubated with Alexa Fluor 488 -or Alexa Fluor 594conjugated secondary antibodies (Molecular Probes, Carlsbad, CA) 1 h at RT. Sections were counterstained with Hoechst (5 mg/mL, Molecular probes, Carlsbad, CA) and mounted in Pro-Long anti-fade mounting solution (Molecular probes, Carlsbad, CA). For DAB staining, sections were exposed to vectastain ABC kit and ImmPACT DAM substrate (Vector lab, Burlingame, CA) according to manufacturer's instructions. b-gal staining was performed on fresh frozen sections as previously described. 25 Tissue culture and hypoxia conditions Animals were sacrificed by decapitation under anesthesia. Neural stem cells were isolated from the SVZ of adult wild type CD1 mice (2-4 months old) and grown as described by Scheffler et al. 52 The ventricle wall on the striatal side was dissected out and the tissue was dissociated in 1.33 mg/mL trypsin, 0.7 mg/mL hyaluronic acid and 0.2 mg/mL kynurenic acid in HBSS, and placed overnight in 100 mm bacterial petri dishes in N2 medium (DMEM/F-12, 100 units/mL penicillin, 100 mg/mL streptomycin, N2 supplement, 35 mg/mL bovine pituitary extract, 5% FBS (Gibco), and 20 ng/mL epidermal growth factor (EGF) and 10 ng/mL (bFGF)). Following overnight incubation, unattached cells were collected, gently triturated and replated onto a fresh 100 mm bacterial petri dish and grown to confluency in N5 medium. Fresh EGF and FGF (20 ng each) were added every other day. Confluent cells were passed once with 0.05% trypsin (Gibco) and plated at 500,000 cells per 100 mm petri dish in N2 medium until grown to 80-90% confluency. For hypoxia exposure: Cells were plated at 2000 cells into each well of a 96-well plate containing 100 mL monolayer media. Following overnight incubation at 37 C, 5% CO 2, plates either remained there or were placed in an airtight oxygen controlled ProOx-C-chamber (BioSpherix Ltd, Redfield NY) housed in a 37 C incubator to maintain constant and appropriate temperature and humidity. The hypoxia chamber was maintained at 1% O 2 , 5% CO 2 by infusing a balanced Nitrogen gas mixture in order to reach and maintain the oxygen level at 1%, which was measured and controlled by a ProOx-C oxygen sensor (Model No. 110, BioSpherix Ltd, Redfield NY). Normoxia control was provided according to each time point. For experiments in which the effect of ephrinB3 (eB3) ligand was examined, ephrinB3 protein aggregates 29 or vehicle control were added to the media just prior to placing the plates in the hypoxia chamber at a concentration of 10 mg/mL per well and incubated up to 72 h. Equal amounts of buffer (vehicle) were added as the control.
Proliferation assessment
After 24, 48 and 72 h incubation, plates were removed and immediately assessed for proliferation by adding 10 mM BrdU. Following 1 h incubation with BrdU, cells were fixed with 10% buffered formalin and incubated in 2 N HCl as previously described. 24 Cells were counterstained Hoechst and analyzed under TRITC/DAPI filters on a Zeiss Axiophot microscope equipped with a CCD camera. Six images per well were acquired by using Cellomics kinetic scan HCS reader (Thermo Fisher) and quantified as percentage of BrdU by VHCS scan software (Thermo Fisher) (TRITC average intensity greater than 100) as previously described. 29 
RT-PCR
Total RNA of monolayers was isolated by applying Trizol reagent (Invitrogen) and following the manufacturer's protocol. RNA quantification was carried out by measuring absorbance with spectrophotometer ND-1000 (NanoDrop). RNA was reverse transcribed into cDNA with Im-Prom II Reverse Transcription System (Promega). The primers for the genes of interest were as follows: ephrinB1, forward: 5 0caccatcaagttccaagat-3 0 , reverse: 5 0 -cttctctcctggttcacag-3 0 ; ephrinB2, forward: 5 0 -tggaagtactgttggggact, reverse: 3 0 -tcacatcttggtctggtctg; ephrinB3, forward: 5 0 -gggaccggctagatctactt-3 0 , reverse: 5 0 -ggctgtattcctggaacttg-3 0 ; EphB1, forward: 5 0 -atccggaacccagctagtctcaag-3 0 , reverse: 5 0 -ggtggtaaaggccgtgaagtctg-3 0 ; EphB2, forward: 5 0 -atccggaacccagctagtctcaag-3 0 , reverse: 5 0 -ggtgtgtaatgtgcgtgagt-3 0 ; EphB3, forward: 5 0ggtgtgtaatgtgcgtgagt-3 0 , reverse: 5 0 -tggtgtccactttcacgtag-3 0 ; EphA4, forward: 5 0 -aggaagtgagcattatggatga-3 0 , reverse: 5 0tgctcctcgtgcccagcgtt-3 0 . The PCR products were loaded on 1% agarose gel and were visualized with ethidium bromide. The reverse transcriptase was omitted in the negative control reaction and cDNA generated from adult mouse brain RNA were used in the positive control reaction. Both controls were applied for each PCR reaction.
Western Blot analysis
Protein of monolayer cultures was extracted by lysing cells in RIPA buffer (1% NP-40, 1% sodium-deoxycholate, 0.1% SDS, 0.15 M NaCl, 2 mM EDTA, and 0.01 M sodium phosphate) in the presence of complete protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail 2 (Sigma). Supernatant was collected by centrifuging at 13,000 g for 30 min at 4 C and the Lowry assay was used for the determination of protein concentration (Pierce, Rockford, IL). Cell lysates (50 mg) were resolved on 8% SDS-PAGE gels and blotted onto PVDF membranes, blocked with 5% milk in TBST buffer (20 mM Tris, 137 mM NaCl and 0.1% Tween) then incubated in block overnight at 4 C with primary antibody against Hif-1 a (mouse, 1:2000 Novus), EphB3 (mouse, 1:1000 ABCAM), phospho-AKT and AKT (rabbit 1:4000 Cell Signaling), or b-actin (mouse, 1:5000 Sigma). HRP-conjugated secondary antibodies (Jackson Laboratory) were applied to the membrane and developed as previously described. 24 Blots were quantified by densitometry using acquisition into Adobe Photo Shop (Apple, Cupertino, CA, USA) and analyzing by the NIH Image software (National Institutes of Health, Bethesda, MD, USA). The level of protein expression was normalized according to b-actin controls or total AKT levels. Samples were run in triplicate.
